第一作者机构:[1]Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China[2]Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China[3]Acad Mil Med Sci, Ctr Canc, Hosp 307, Beijing, Peoples R China[4]Shanghai Pulm Hosp, Shanghai, Peoples R China[5]Perking Union Med Hosp, Beijing, Peoples R China[6]Third Mil Med Univ Peoples Liberat Army, Affiliated Hosp 3, Chongqing, Peoples R China[7]Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China[8]Capital Med Univ, Bejiing Chest Hosp, Beijing, Peoples R China[9]Nanjing Bayi Hosp, Nanjing, Jiangsu, Peoples R China[10]Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China[11]Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China[12]Hunan Canc Hosp, Changsha, Hunan, Peoples R China[13]Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing, Jiangsu, Peoples R China[14]Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China[15]Jilin Prov Canc Hosp, Changchun, Peoples R China[16]Fourth Mil Med Univ, Tangdu Hosp, Xian 710032, Peoples R China[17]Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou, Guangdong, Peoples R China[18]Guangdong Acad Med Sci, Guangzhou, Guangdong, Peoples R China[19]Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Med Oncol, Hangzhou, Zhejiang, Peoples R China[20]Zhejiang Univ, Coll Med, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China
推荐引用方式(GB/T 7714):
Sun Yan,Shi Yuankai,Zhang Li,et al.Final overall survival and updated biomarker analysis results from the randomized phase III ICOGEN trial.[J].JOURNAL OF CLINICAL ONCOLOGY.2012,30(15):-.
APA:
Sun, Yan,Shi, Yuankai,Zhang, Li,Liu, Xiaoqing,Zhou, Caicun...&Zhou, Jianying.(2012).Final overall survival and updated biomarker analysis results from the randomized phase III ICOGEN trial..JOURNAL OF CLINICAL ONCOLOGY,30,(15)
MLA:
Sun, Yan,et al."Final overall survival and updated biomarker analysis results from the randomized phase III ICOGEN trial.".JOURNAL OF CLINICAL ONCOLOGY 30..15(2012):-